On the contrary, miRNA-195-5p, elevated in AD and sCJD, downregulates Aβ production by targeting APP and BACE1, and protects against chronic brain hypoperfusion-mediated dementia [89]. The gene discussed is BACE1; the disease is Alzheimer disease.